Giuseppe Procopio

2 ta ish

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

1. Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?

   Matteo Santoni, Sebastiano Buti, Zin Myint +63

   Maqola20233 iqtibos

   ABIABI:AkademIndex/2026.other.839256

2. Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

   Robert J. Motzer, Bernard Escudier, Ray McDermott +24

   Maqola20152 iqtibos

   ABIABI:AkademIndex/2026.other.679071